从文献到假设:一种用于生物标志物引导的药物组合假设生成的AI合作者系统
From Literature to Hypotheses: An AI Co-Scientist System for Biomarker-Guided Drug Combination Hypothesis Generation
AI总结:
本文提出 AI 合作者系统 CoDHy,通过整合生物医学知识图谱和文献证据,实现基于生物标志物的药物组合假设生成与验证。
摘要:
生物医学文献和 curated 数据库的快速增长使研究人员系统地将生物标志物机制与可操作的药物组合假设联系起来变得更加困难。我们提出了 AI 合作者(CoDHy),一种用于癌症研究中生物标志物引导的药物组合假设生成的交互式、人机协作系统。CoDHy 将结构化的生物医学数据库和非结构化的文献证据整合到任务特定的知识图谱中,该图谱作为基于图的推理和假设构建的基础。该系统结合知识图谱嵌入与基于代理的推理,生成、验证和排序候选药物组合,同时明确将每个假设根植于可检索的证据中。通过基于网页的界面,用户可以配置科学背景,检查中间结果,并迭代优化假设,从而实现透明且由研究人员控制的探索,而不是自动化决策。我们展示了 CoDHy 作为一种在转化肿瘤学中用于探索性假设生成和决策支持的系统,突显了其设计、交互流程和实际应用案例。
英文摘要:
The rapid growth of biomedical evidence makes it difficult to translate biomarker mechanisms into actionable drug combination hypotheses. We present CoDHy, an interactive AI co-scientist for biomarker-guided hypothesis generation in oncology. CoDHy constructs task-specific knowledge graphs from curated databases and biomedical literature, then combines graph embeddings with agent-based reasoning to generate, validate, and rank evidence-grounded drug combinations. Through a web interface, researchers specify the biomarker, cancer context, and literature scope; inspect supporting evidence and intermediate results; and iteratively refine the generated hypotheses. The demonstration presents CoDHy's end-to-end workflow and shows how researchers can interactively explore and compare mechanistically supported drug combinations while remaining in control of hypothesis prioritization.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。